Skip to Main Content

Author Details

David I Rosenthal
MD Anderson Cancer Center
1987
366
70
PMIDPaper TitleJournal TitlePublished Year
36228746Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504.Int J Radiat Oncol Biol Phys2023
38058404Patterns of failure for recurrent head and neck squamous cell carcinoma treated with salvage surgery and postoperative IMRT reirradiation.Clin Transl Radiat Oncol2023
37790305Longitudinal Changes in the Carotid Arteries of Head and Neck Cancer Patients Following Radiation Therapy: Results from a Prospective Serial Imaging Biomarker Characterization Study.medRxiv2023
37686597Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio.Cancers (Basel)2023
37568810Methylene Blue for the Treatment of Radiation-Induced Oral Mucositis during Head and Neck Cancer Treatment: An Uncontrolled Cohort.Cancers (Basel)2023
37535378Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck: Secondary Analysis of a Phase 2 Clinical Trial.JAMA Otolaryngol Head Neck Surg2023
37205359Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5T MR-Linear accelerator hybrid system: A prospective R-IDEAL Stage 2a imaging biomarker characterization/ pre-qualification study.medRxiv2023
37165701Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experience.Head Neck2023
36549347Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.Int J Radiat Oncol Biol Phys2023
36720835ASO Visual Abstract: Impact of Cancer Care Regionalization on Patient Volume.Ann Surg Oncol2023
36581726Impact of Cancer Care Regionalization on Patient Volume.Ann Surg Oncol2023
34729846Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522.Head Neck2022
35504500Unilateral Radiation Therapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papillomavirus, Positron-Emission Tomography, and Intensity Modulated Radiation Therapy.Int J Radiat Oncol Biol Phys2022
35603438Cross-Cultural Brain Activity Differences Between True and Sham Acupuncture for Xerostomia During Head and Neck Cancer Radiotherapy.Integr Cancer Ther2022
35594776Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival.Oral Oncol2022
35419587Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.Clin Cancer Res2022
36420184Evolutionary Action Score of <i>TP53</i> Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234.Adv Radiat Oncol2022
36135064Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study.Curr Oncol2022
35308916Feasibility of Mobile and Sensor Technology for Remote Monitoring in Cancer Care and Prevention.AMIA Annu Symp Proc2022
35060430The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patients.Acta Oncol2022
33320343Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck.Cancer2021
33522021Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck.Head Neck2021
33571626International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma.Int J Radiat Oncol Biol Phys2021
33878727Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care.J Natl Compr Canc Netw2021
33873251Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.Cancer2021
33788956The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.Cancer2021
33736997Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy.Radiother Oncol2021
33814339The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.J Geriatr Oncol2021
33640577Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522.Oral Oncol2021
33888069Vocal-cord Only vs. Complete Laryngeal radiation (VOCAL): a randomized multicentric Bayesian phase II trial.BMC Cancer2021
34524729Therapeutic approaches and outcomes in patients with larynx or hypopharynx high-grade neuroendocrine carcinoma: A single-center retrospective analysis.Head Neck2021
34430717Factors associated with complex oral treatment device usage in patients with head and neck cancer.Clin Transl Radiat Oncol2021
34841093Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy.Clin Transl Radiat Oncol2021
34187851Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.Clin Cancer Res2021
34269492Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.Head Neck2021
34358340Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma.Cancer2021
34285958Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer.Int J Part Ther2021
34285952Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes.Int J Part Ther2021
34285950Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life.Int J Part Ther2021
34285948Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer.Int J Part Ther2021
34285940Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience.Int J Part Ther2021
34283635Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.J Clin Oncol2021
34195391<sup>18</sup>FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer.Clin Transl Radiat Oncol2021
34086150Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.Curr Treat Options Oncol2021
33277960Defining the dose-volume criteria for laryngeal sparing in locally advanced oropharyngeal cancer utilizing split-field IMRT, whole-field IMRT and VMAT.J Appl Clin Med Phys2021
33217499Development and validation of a contouring guideline for the taste bud bearing tongue mucosa.Radiother Oncol2021
33306202Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis.Cancer2021
33051590Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy.Br J Cancer2021
33360375Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation.Oral Oncol2021
33352413Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck.Eur J Cancer2021
  • 1 - 50 of 366

Recommended Authors

Jason W Chan
University of California San Francisco
Career Start Year 2017
Number of shared co-authors 4
Ali Hosni
Princess Margaret Cancer Center
Career Start Year 2015
Number of shared co-authors 7
Krupal B Patel
Moffitt Cancer Center
Career Start Year 2013
Number of shared co-authors 5
Ryan K Orosco
university of california san diego
Career Start Year 2010
Number of shared co-authors 5
Katharine A Price
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 8
Ryan Li
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 7
Julie E Bauman
George Washington University
Career Start Year 2007
Number of shared co-authors 6
Daniel J Ma
Mayo Clinic
Career Start Year 2005
Number of shared co-authors 9
David P Goldstein
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2005
Number of shared co-authors 14
Daniel R Clayburgh
Oregon Health & Science University
Career Start Year 2004
Number of shared co-authors 1
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 1
Ezra E W Cohen
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 15
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 14
Barbara Bachtiary
Center for Proton Therapy, Paul Scherrer Institute
Career Start Year 2000
Number of shared co-authors 0
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 8
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 14
Frank J P Hoebers
Maastricht University Medical Centre
Career Start Year 1999
Number of shared co-authors 13
Sean M McBride
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 9
Patrick K Ha
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 7
Richard J Wong
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 11
Umamaheswar Duvvuri
University of Pittsburgh School of Medicine
Career Start Year 1997
Number of shared co-authors 7
Jonathan C Irish
Princess Margaret Cancer Centre
Career Start Year 1992
Number of shared co-authors 9
Charles R Leemans
Location Vrije Universiteit Amsterdam
Career Start Year 1990
Number of shared co-authors 11
William F Hartsell
Proton Therapy Center- Northwestern University
Career Start Year 1989
Number of shared co-authors 4
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 10
Wayne M Koch
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 6
Johannes H A M Kaanders
Radboud University Medical Center
Career Start Year 1987
Number of shared co-authors 7
Danielle Van den Weyngaert
University of Antwerp
Career Start Year 1987
Number of shared co-authors 3
David G Pfister
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 13
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 2

Collaborators

Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Co-authored papers 137
Adel K El-Naggar
MD Anderson Cancer Center
Co-authored papers 54
Beth M Beadle
Stanford University
Co-authored papers 41
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Co-authored papers 38
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Co-authored papers 25
Musaddiq J Awan
Medical College of Wisconsin
Co-authored papers 13
Charles Lu
Co-authored papers 12
Carlos E Cardenas
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
Michelle D Williams
The University of Texas M. D. Anderson Cancer Center
Co-authored papers 11
Radhe Mohan
The University of Texas MD Anderson Cancer Center
Co-authored papers 10
Christopher U Jones
Sutter Medical Center Sacramento
Co-authored papers 8
Jayashree Kalpathy-Cramer
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
Co-authored papers 8
Benjamin D Smith
Co-authored papers 8
Hesham Elhalawani
Co-authored papers 7
Rivka R Colen
Co-authored papers 7
Robert L Foote
Mayo Clinic
Co-authored papers 6
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 6
Nancy Y Lee
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Lifei Zhang
The University of Texas MD Anderson Cancer Center.
Co-authored papers 5
Deborah W Bruner
Emory University, USA Winship Cancer Institute, USA School of Medicine
Co-authored papers 5
Jinzhong Yang
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Coen R N Rasch
Leiden University Medical Center
Co-authored papers 5
Laurence E Court
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Andr?? Fortin
Laval University, CHU de Quebec
Co-authored papers 5
Peter Balter
University of Texas MD Anderson Cancer Center
Co-authored papers 4
Qingyi Wei
South China University of Technology
Co-authored papers 4
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Co-authored papers 3
Stephen T Sonis
Brigham and Women's Hospital
Co-authored papers 3
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Andre Konski
Chester County Hospital
Co-authored papers 3
Release 1.2